Head India Market Access

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use.  I further attest that all information I submit in my employment application is true to the best of my knowledge.

Shape the access environment and translate India’s portfolio ambitions into meaningful patient access and business growth through integrated pricing, value, evidence, institutional and public-access strategies.

The Director, Patient & Market Access, India is a senior country leadership role responsible for shaping and delivering the access strategies that enable greater patient access and achievement of India’s business ambitions.

As a member of the India Country Leadership Team, the role will provide enterprise-level leadership across Market Access, ensuring that access considerations are embedded early in portfolio strategy, launch planning and business decision-making.

The Director will lead the India Market Access function across pricing and value strategy, patient access, institutional and public-market access, reimbursement and funding pathways, tender and contracting strategy, health economics and access excellence.

India requires differentiated approaches across private, institutional and public channels. The role will therefore work closely with Commercial, Medical, Public Affairs, Finance, Regulatory, Legal/E&C and regional/global Market Access teams to translate portfolio strategy into viable access pathways while balancing patient access, business growth and long-term portfolio value.

The role requires a leader who can operate at both strategic and executional altitude, shaping the external access environment, advising the Country Leadership Team on critical access choices, and mobilizing cross-functional teams behind major access priorities.

• Develop and lead the India Market Access strategy across the portfolio, translating country and brand ambitions into clear access priorities, investment choices and measurable outcomes.
• Represent Market Access on the Country Leadership Team, bringing a strong patient access, pricing, value and health-system perspective to business decisions.
• Ensure access strategy is integrated early into portfolio prioritization, launch planning, lifecycle management and business planning.
• Anticipate changes in the Indian healthcare and access environment and translate them into strategic implications and actions for the business.

• Provide strategic leadership for launch pricing, price architecture, contracting, tender economics and lifecycle price management.
• Develop strategies that balance patient access, competitive positioning, commercial opportunity and long-term portfolio value.
• Lead organizational thinking on price-volume trade-offs, value recognition and differentiated access models.
• Ensure appropriate alignment between India pricing decisions and applicable regional and global pricing governance.

• Design differentiated access strategies across private, institutional, public-sector and other relevant funding and procurement channels.
• Identify and address barriers preventing patients from accessing Takeda innovations.
• Develop appropriate patient access and affordability approaches while ensuring strong governance and long-term viability.
• Translate successful access approaches into scalable models where appropriate.

• Shape the Market Access strategy for government institutions, public-sector accounts and state-level opportunities.
• Provide strategic direction on account prioritization, procurement pathways, tenders, contracting and funding approaches.
• Partner cross-functionally to build the evidence, stakeholder support and implementation readiness required to progress from access strategy to funded patient access.
• Develop repeatable models that can progressively broaden access across India's complex healthcare landscape.

• Lead the access evidence strategy required to demonstrate the clinical, economic and societal value of Takeda's portfolio.
• Guide the development and application of health economics, outcomes research, budget-impact, cost-effectiveness and real-world evidence to support access decisions.
• Translate complex clinical and economic evidence into compelling value propositions for different stakeholders.
• Partner with Medical and other functions to identify and close evidence gaps that could constrain access.

• Provide strategic Market Access leadership for vaccines and other products requiring public-health, institutional or government pathways.
• Integrate pricing, evidence, economic value, funding and implementation considerations into public-access strategies.
• Partner with Medical, Public Affairs and Commercial teams to create the conditions required for broader public-health access.
• Build scalable access approaches that can evolve from initial market introduction toward broader institutional and public access.

• Build credible, senior engagement with relevant payers, government and institutional stakeholders, procurement bodies, HTA stakeholders and other healthcare decision-makers, in partnership with appropriate internal functions.
• Anticipate policy, pricing, procurement and healthcare-system developments with the potential to affect access.
• Navigate complex stakeholder environments and negotiations while maintaining strong standards of ethics, compliance and governance.
• Represent perspectives relevant to patient access through appropriate industry and healthcare forums.

• Mobilize Commercial, Medical, Public Affairs, Finance, Regulatory, Legal/E&C and other partners around critical Market Access priorities.
• Establish clear cross-functional objectives, decision points, accountabilities and governance for major access initiatives.
• Identify access barriers early and influence senior stakeholders to resolve them.
• Ensure Market Access acts as an enterprise business partner, rather than operating as a standalone functional capability.

• Provide strategic direction and leadership to the India Market Access team and its key capabilities.
• Develop a high-performing organization with strong expertise in pricing and value, institutional/public access, patient access, tender strategy, evidence and analytics.
• Coach and develop team members and future leaders, strengthening strategic thinking, external engagement and execution capability.
• Establish appropriate KPIs, governance and operating rhythms connecting Market Access activities to patient, access and business outcomes.
• Manage resources and investments with clear prioritization and accountability for impact.

The successful candidate will bring:

• Significant leadership experience in Market Access, pricing, reimbursement, health economics, public/institutional access or related disciplines, ideally within the Indian pharmaceutical, biotechnology or vaccines environment.
• Strong understanding of the Indian healthcare and access landscape, including public and private healthcare channels, institutional procurement, tendering, patient access and relevant pricing regulation.
• Demonstrated ability to develop and execute enterprise-level Market Access strategies across multiple products or therapeutic areas.
• Strong strategic pricing capabilities, including launch pricing, value-based decision-making, contracting, tenders, price-volume considerations and lifecycle management.
• Strong understanding of HEOR, value communication, budget-impact and cost-effectiveness methodologies and their application to access decision-making.
• Experience developing differentiated strategies for government/public institutions, private healthcare channels and patient-funded markets.
• Strong track record of influencing complex cross-functional decisions and aligning senior stakeholders behind common objectives.
• Excellent negotiation, stakeholder-management and executive communication capabilities.
• Demonstrated ability to engage credibly with senior external healthcare stakeholders and decision-makers.
• Strong knowledge of the biopharmaceutical industry, with experience across innovative medicines, specialty care and/or vaccines highly desirable.
• Proven people leadership and talent-development capability, including experience leading senior professionals and building high-performing teams.
• Ability to balance strategic leadership with executional discipline, maintaining focus on the initiatives with the greatest patient and business impact.
• Strong judgment and ability to operate effectively in complex, evolving and ambiguous environments.

This is a strategic leadership role rather than a primarily operational position.

The Director will be expected to:

• Think and act as an India enterprise leader, beyond the boundaries of the Market Access function.
• Bring a clear access perspective to Country Leadership Team decisions and challenge constructively when access assumptions could affect portfolio potential.
• Translate long-term strategy into a limited number of high-impact priorities with clear accountability for execution.
• Make informed trade-offs across patient access, value, affordability, investment and business opportunity.
• Build strong partnerships internally and externally and create alignment across stakeholders with different priorities.
• Develop the organization and capabilities required for India's evolving access environment.
• Maintain the highest standards of integrity, compliance and responsible engagement.